192 related articles for article (PubMed ID: 34823828)
21. Computer-Aided Tomographic Analysis of Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Correlation with Pulmonary Physiologic Tests and Patient-Centred Measures of Perceived Dyspnea and Functional Disability.
Salaffi F; Carotti M; Di Donato E; Di Carlo M; Ceccarelli L; Giuseppetti G
PLoS One; 2016; 11(3):e0149240. PubMed ID: 26930658
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous and serologic subsets of systemic sclerosis.
Ferri C; Bernini L; Cecchetti R; Latorraca A; Marotta G; Pasero G; Neri R; Bombardieri S
J Rheumatol; 1991 Dec; 18(12):1826-32. PubMed ID: 1795320
[TBL] [Abstract][Full Text] [Related]
23. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
[TBL] [Abstract][Full Text] [Related]
24. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
Coelho Horimoto AM; da Costa IP
Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
[TBL] [Abstract][Full Text] [Related]
25. Correlation of delta high-resolution computed tomography (HRCT) score with delta clinical variables in early systemic sclerosis (SSc) patients.
Wangkaew S; Euathrongchit J; Wattanawittawas P; Kasitanon N
Quant Imaging Med Surg; 2016 Aug; 6(4):381-390. PubMed ID: 27709074
[TBL] [Abstract][Full Text] [Related]
26. Systemic Sclerosis in Zimbabwe: Autoantibody Biomarkers, Clinical, and Laboratory Correlates.
Sibanda EN; Dube Y; Chakawa M; Mduluza T; Mutapi F
Front Immunol; 2021; 12():679531. PubMed ID: 34858387
[TBL] [Abstract][Full Text] [Related]
27. Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China.
Zhang SZ; Xu D; Li MT; Hou Y; Wang Q; Tian Z; Liu YT; Guo XX; Lai JZ; Zhao JL; Hu CJ; Song N; Sun QN; Zhang FC; Zhao Y; Zeng XF
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S106-10. PubMed ID: 26005882
[TBL] [Abstract][Full Text] [Related]
28. Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database.
Morgan ND; Shah AA; Mayes MD; Domsic RT; Medsger TA; Steen VD; Varga J; Carns M; Ramos PS; Silver RM; Schiopu E; Khanna D; Hsu V; Gordon JK; Gladue H; Saketkoo LA; Criswell LA; Derk CT; Trojanowski MA; Shanmugam VK; Chung L; Valenzuela A; Jan R; Goldberg A; Remmers EF; Kastner DL; Wigley FM; Gourh P; Boin F
Medicine (Baltimore); 2017 Dec; 96(51):e8980. PubMed ID: 29390428
[TBL] [Abstract][Full Text] [Related]
29. Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study.
Wangkaew S; Euathrongchit J; Wattanawittawas P; Kasitanon N; Louthrenoo W
Mod Rheumatol; 2016 Jul; 26(4):588-93. PubMed ID: 26561397
[TBL] [Abstract][Full Text] [Related]
30. Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database.
Carreira PE; Carmona L; Joven BE; Loza E; Andréu JL; Riemekasten G; Vettori S; Balbir-Gurman A; Airò P; Walker U; Damjanov N; Matucci-Cerinic M; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Allanore Y
Scand J Rheumatol; 2019 Jan; 48(1):42-51. PubMed ID: 30039730
[TBL] [Abstract][Full Text] [Related]
31. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
[TBL] [Abstract][Full Text] [Related]
32. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
33. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.
Carreira PE; Carmona L; Joven BE; Loza E; Andreu JL; Riemekasten G; Vettori S; Balbir-Gurman A; Airò P; Walker UA; Damjanov N; Matucci-Cerinic M; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Allanore Y;
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):68-75. PubMed ID: 30277860
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of anti-NOR90 antibodies in systemic sclerosis and idiopathic interstitial pneumonia.
Yamashita Y; Yamano Y; Muro Y; Ogawa-Momohara M; Takeichi T; Kondoh Y; Akiyama M
Rheumatology (Oxford); 2022 Apr; 61(4):1709-1716. PubMed ID: 34282441
[TBL] [Abstract][Full Text] [Related]
35. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and risk factors of systemic sclerosis-associated interstitial lung disease in East Asia: A systematic review and meta-analysis.
Qiu M; Nian X; Pang L; Yu P; Zou S
Int J Rheum Dis; 2021 Dec; 24(12):1449-1459. PubMed ID: 34418313
[TBL] [Abstract][Full Text] [Related]
37. Anti-carbamylated protein antibodies in systemic sclerosis.
Liem SIE; Hoekstra EM; Levarht EWN; Dorjee AL; Scherer HU; Toes REM; Huizinga TWJ; de Vries-Bouwstra JK; Fehres CM
Arthritis Res Ther; 2023 Jul; 25(1):123. PubMed ID: 37480150
[TBL] [Abstract][Full Text] [Related]
38. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.
Iniesta Arandia N; Simeón-Aznar CP; Guillén Del Castillo A; Colunga Argüelles D; Rubio-Rivas M; Trapiella Martínez L; García Hernández FJ; Sáez Comet L; Egurbide Arberas MV; Ortego-Centeno N; Freire M; Marí Alfonso B; Vargas Hitos JA; Ríos Blanco JJ; Todolí Parra JA; Rodríguez-Carballeira M; Marín Ballvé A; Chamorro Fernández AJ; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Espinosa G;
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):98-105. PubMed ID: 28980912
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
[TBL] [Abstract][Full Text] [Related]
40. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]